Soy protein modification of rat polycystic kidney disease

American Journal of Physiology - Renal Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Ogborn, Malcolm R ^a,b   Bankovic Calic, Neda ^a   Shoesmith, Christen ^a   Buist, Richard ^a   Peeling, James ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NONE   (Canada)

Author keywords

Casein; Fibrosis; Han:SPRD cy rat; Proton nuclear magnetic resonance; Renal inflammation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FIBROSIS; GENE MUTATION; KIDNEY INFECTION; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN MODIFICATION; PROTEIN RESTRICTION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

EID: 0031921076     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.274.3.f541     Document Type: Article

References (53)

1. Acott, P. D., M. R. Ogborn, and J. F. Crocker. Chronic renal failure in the rat. A surgical model for long-term toxicological studies. J. Pharmacol. Methods 18: 81-88, 1987.
2. Anderson, R. L., and W. J. Wolf. Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J. Nutr. 125: 581S-588S, 1995.
3. Anthony, M. L., K. P. Gartland, C. R. Beddell, J. C. Lindon, and J. K. Nicholson. Studies of the biochemical toxicology of uranyl nitrate in the rat Arch. Toxicol. 68: 43-53, 1994.
4. Anthony, M. S., T. B. Clarkson, C. L. Hughes, Jr., T. M. Morgan, and G. L. Burke. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of prepubertal rhesus monkeys. J. Nutr. 126: 43-50, 1996.
5. Bachmann, S., K. Ramasubbu, K. Schafer, S. Uiker, and N. Gretz. Tubulointerstitial changes in the Han:SPRD rat model for ADPKD. Contrib. Nephrol. 115: 113-117, 1995.
6. Bankovic-Calic, N., A. Eddy, and M. R. Ogborn. Protein restriction reduces inflammation and fibrosis more than tubular proliferation in the cy/+ rat (Abstract). J. Am. Soc. Nephrol. 7: 1728, 1996.
7. Barak, A. J., H. C. Beckenhauer, and D. J. Tuma. S-adenosylmethionine generation and prevention of alcoholic fatty liver by betaine. Alcohol 11: 501-503, 1994.
8. Bell, J. D., P. J. Sadler, V. C. Morris, and O. A. Levander. Effect of aging and diet on proton NMR spectra of rat urine. Magn. Reson. Med. 17: 414-422, 1991.
9. Burg, M. B. Molecular basis of osmotic regulation. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F983-F996, 1995.
10. Carlisle, E., S. Donnelly, and M. Halperin. Renal tubular acidosis: recognize the ammonium defect and pHorget the pH. Pediatr. Nephrol. 5: 242-248, 1991.
11. Chan, L., and J. I. Shapiro. Magnetic resonance study of renal transplantation. Renal Physiol. Biochem. 12: 181-190, 1991.
12. Clark, W. F., A. Parbtani, D. J. Philbrick, E. Spanner, M. W. Huff, and B. J. Holub. Dietary protein restriction versus fish oil supplementation in the chronic remnant nephron model. Clin. Nephrol. 39: 295-304, 1993.
13. Cohen, A. H. Masson's trichrome stain in the evaluation of renal biopsies. Am. J. Clin. Pathol. 65: 631-643, 1975.
14. Cowley, B. D., Jr., S. Gudapaty, A. L. Kraybill, B. D. Barash, M. A. Harding, J. P. Calvet, and V. H. D. Gattone. Autosomal-dominant polycystic kidney disease in the rat. Kidney Int. 43: 522-534, 1993.
15. Diamond, J. R., and S. Anderson. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis: amelioration by angiotensin I converting enzyme inhibition. Am. J. Pathol. 137: 1323-1332, 1990.
16. Dixon, R. M., and J. Frahm. Localized proton MR spectroscopy of the human kidney in vivo by means of short echo time STEAM sequences. Magn. Reson. Med. 31: 482-487, 1994.
17. Eddy, A. A. Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephrotic syndrome. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F884-F893, 1994.
18. Eddy, A. A. Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia. Kidney Int. 50: 1139-1149, 1996.
19. Foxall, P. J., R. G. Price, J. K. Jones, G. H. Neild, F. D. Thompson, and J. K. Nicholson. High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease. Biochim. Biophys. Acta 1138: 305-314, 1992.
20. Gattone, V. H., II, B. D. Cowley, Jr., B. D. Barash, S. Nagao, H. Takahashi, T. Yamaguchi, and J. J. Grantham. Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents. Am. J. Kidney Dis. 25: 302-313, 1995.
21. Gile, R. D., B. D. Cowley, Jr., V. H. Gattone II, O. D. Mp, S. K. Swan, and J. J. Grantham. Effect of lovastatin on the development of polycystic kidney disease in the Han: SPRD rat. Am. J. Kidney Dis. 26: 501-507, 1995.
22. Grantham, J. J. Polycystic kidney disease: hereditary and acquired. Adv. Intern. Med. 38: 409-420, 1993.
23. Gretz, N., I. Ceccherini, B. Kranzlin, I. Kloting, M. Devoto, P. Rohmeiss, B. Hocher, R. Waldherr, and G. Romeo. Gender-dependent disease severity in autosomal polycystic kidney disease of rats. Kidney Int. 48: 496-500, 1995.
24. Grossman, E. B., and S. C. Hebert. Renal inner medullary choline dehydrogenase activity: characterization and modulation. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): F107-F112, 1989.
25. Hughes, J., C. J. Ward, B. Peral, R. Aspinwall, K. Clark, J. L. San Millan, V. Gamble, and P. C. Harris. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10: 151-160, 1995.
26. Iwasaki, K., C. A. Gleiser, E. J. Masoro, C. A. McMahan, E. J. Seo, and B. P. Yu. The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J. Gerontol. A Biol. Sci. Med. Sci. 43: B5-B12, 1988.
27. Keith, D. S., V. E. Torres, C. M. Johnson, and K. E. Holley. Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats. Am. J. Kidney Dis. 24: 491-498, 1994.
28. Le Moyec, L., A. Pruna, M. Eugene, J. Bedrossian, J. M. Idatte, J. F. Huneau, and D. Tome. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron 65: 433-439, 1993.
29. Liener, I. E. Possible adverse effects of soybean anticarcinogens. J. Nutr. 125, Suppl. 3: 744s-750s, 1995.
30. Maeda, H., C. A. Gleiser, E. J. Masoro, I. Murata, C. A. McMahan, and B. P. Yu. Nutritional influences on aging of Fischer 344 rats: II. Pathology. J. Gerontol. A Biol. Sci. Med. Sci. 40: 671-688, 1985.
31. Masoro, E. J., K. Iwasaki, C. A. Gleiser, C. A. McMahan, E. J. Seo, and B. P. Yu. Dietary modulation of the progression of nephropathy in aging rats: an evaluation of the importance of protein. Am. J. Clin. Nutr. 49: 1217-1227, 1989.
32. Modification Of Diet In Renal Disease Study Group. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. J. Am. Soc. Nephrol. 5: 2037-2047, 1995.
33. Nadasdy, T., Z. Laszik, G. Lajoie, K. E. Blick, D. E. Wheeler, and F. G. Silva. Proliferative activity of cyst epithelium in human renal cystic diseases. J. Am. Soc. Nephrol. 5: 1462-1468, 1995.
34. Nagata, Y., N. Ishikawi, and M. Sugano. Studies on the mechanism of antihypercholesterolemic action of soy protein and soy protein-type amino acid mixtures in relation to the casein counterpart s in rats. J. Nutr. 112: 1614-1625, 1982.
35. Nicholson, J. K., J. A. Timbrell, and P. J. Sadler. Proton NMR spectra of urine as indicators of renal damage. Mercury-induced nephrotoxicity in rats. Mol. Pharmacol. 27: 644-651, 1985.
36. Oghorn, M. R., and S. Sareen. Amelioration of polycystic kidney disease by modification of dietary protein intake in the rat. J. Am. Soc. Nephrol. 6: 1649-1654, 1995.
37. Ogborn, M. R., S. Sareen, and G. Pinette. Cilazapril delays progression of hypertension and uremia in rat polycystic kidney disease. Am. J. Kidney Dis. 26: 942-946, 1995.
38. Ogborn, M. R., S. Sareen, J. Prychitko, R. Buist, and J. Peeling. Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study. Am. J. Physiol. 272 (Renal Physiol. 41): F63-F69, 1997.
39. Peeling, J., T. Shoemaker, T. Gauthier, A. Benarroch, G. R. Sutherland, and G. Y. Minuk. Cerebral metabolic and histologic effects of thioacetamide-induced liver failure. Am. J. Physiol. 265 (Gastrointest. Liver Physiol. 28): G572-G578, 1993.
40. Peters, D. J., L. Spruit, J. J. Saris, D. Ravine, L. A. Sandkuijl, R. Fossdal, J. Boersma, R. Van Eijk, S. Norby, C. D. Constantinou Deltas, A. Pierides, J. E. Brissenden, R. R. Frants, G.-J. B. van Ommen, and M. H. Breuning. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat. Genet. 5: 359-362, 1993.
41. Pugh, J. L., W. E. Sweeney, Jr., and E. D. Avner. Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. Kidney Int. 47: 774-781, 1995.
42. Qian, F., F. J. Germino, Y. Cai, S. Somlo, and G. G. Germino. PKD1 interacts with PKD2 through a probable coiled coil domain (Abstract). J. Am. Soc. Nephrol. 7: 1620, 1996.
43. Remuzzi, G., P. Ruggenenti, and A. Benigni. Understanding the nature of renal disease progression. Kidney Int. 51: 2-15, 1997.
44. Shimokawa, I., Y. Higami, G. B. Hubbard, C. A. McMahan, E. J. Masoro, and B. P. Yu. Diet and the suitability of the male Fischer 344 rat as a model for aging research. J. Gerontol. A Biol. Sci. Med. Sci. 48: B27-B32, 1993.
45. Terasawa, F., Y. Hirano, M. Wada, T. Takita, K. Nakamura, and S. Innami. Effects of dietary casein and soy-protein on metabolic conversion of eicosapentaenoic acid to docosahexaenoic acid in the liver of rat. J. Nutr. Sci. Vitaminol. (Tokyo) 40: 353-362, 1994.
46. Torres, V. E., D. K. Mujwid, D. M. Wilson, and K. H. Holley. Renal cystic disease and ammoniagenesis in Han:SPRD rats. J. Am. Soc. Nephrol. 5: 1193-1200, 1994.
47. Towner, R. A., T. Yamaguchi, D. J. Philbrick, B. J. Holub, E. G. Janzen, and H. Takahashi. In vivo proton magnetic resonance imaging and localized spectroscopic analysis of polycystic kidney disease in DBA/2FG-pyc mice. Magn. Reson. Imaging 9: 429-434, 1991.
48. Weibel, E. R. Stereological Methods: Practical Methods For Biologic Morphometry vol. 1, 1979.
49. Williams, A. J., and J. Walls. Metabolic consequences of differing protein diets in experimental renal disease. Eur. J. Clin. Invest. 17: 117-122, 1987.
50. Wilson, P. D., J. T. Norman, N. T. Kuo, and C. R. Burrow. Abnormalities in extracellular matrix regulation in autosomal dominant polycystic kidney disease. Contrib. Nephrol. 118: 126-134, 1996.
51. Woo, D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N. Engl. J. Med. 333: 18-25, 1995.
52. Yushmanov, V. E. Evaluation of radiation injury by H and P NMR of human urine. Magn. Reson. Med. 31: 48-52, 1994.
53. Zerres, K., G. Mucher, L. Bachner, G. Deschennes, T. Eggermann, H. Kaariainen, M. Knapp, T. Lennert, J. Misselwitz, K. E. Von Muhlendahl, H. P. H. Neumann, Y. Pirson, S. Rudnik-Schoneburn, V. Steinbicker, B. Wirth, and K. Scharer. Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen. Nat. Genet. 7: 429-432, 1994.